IRCT20191213045717N1
Recruiting
Phase 3
Comparative Trial of Botulinum Toxin Type A and Methylprednisolone for The Treatment of Piriformis Syndrome
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patients age : 20 years or older
- •Screening of patients for clinically significant Lumbar disk herniation or Lumbosacral radiculopathy by Magnetic Resonance Imaging
- •Trigger point and tenderness in their Gluteal area
- •Pain in their buttocks radiating toward their thigh or lower limb and increasing with prolonged sitting and walking and during bending
- •Increased pain through passive forced hip flexion, adduction, and internal rotation (FAIR position), and pain when the leg was flexed at the knee and the hip was passively and medially rotated (Freiberg test)
- •Having pain for more than 3 months despite the conservative treatment and those whose individual minimum pain severity scores will be greater than 5 on a 10\-point numeric rating scale (VAS criteria)
Exclusion Criteria
- •Known allergy or sensitivity to botulinum toxin type A
- •Previous use of botulinum toxin type A or B
- •Current or planned pregnancy
- •Disorders affecting the Neuromuscular junction or Motor neuron disease,Neurologic deficits found during Electromyelography
- •Administration of Amino\- Glycosides or other drugs that interfere with Neuromuscular transmission
- •Previous Micro\- surgery or Macro\-surgery for disc disease, and any Epidural block within 7 weeks of enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 3
medical versus surgical treatment in idiopathic clubfoot patientsCTRI/2021/01/030466AIIMS RAIPUR
Recruiting
Phase 3
Efficacy of MASPORT in BlepharospasmBenign Essential Blepharospasm (BEB).BlepharospasmG24.5IRCT20240216061023N1Shahid Beheshti University of Medical Sciences19
Completed
Phase 3
Comparative Efficacy of Botulinum Toxin Type A Injection Versus Placebo in the Correction of gummy Smile Between Khat Chewers and Non-Khat Chewers : A Randomized Clinical TrialExcessive gingival display ( gummy smile) measurment ( 3 - 8 mm ) due to hyperactive lip and short lip. measurment of the upper lip lenghand lip mobilitymeasurment of CEJCephalometric analysisGummy smile - Botox - Placebo - khat chewer - non khat chwereTCTR20240719004Hospital of Stomatology of Sana a University45
Not Yet Recruiting
N/A
Assessment of Botulinum Toxin Type A in the Treatment of Hand EczemaPACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60
Recruiting
Phase 2
Botulinum Toxin Type A with Needle-free Injector System in Palmar HyperhidrosisPalmar hyperhidrosisJPRN-jRCTs041180067Ohshima Yuichiro25